Want to track FUM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
FUM trading today higher at 0.6 GBX, an increase of 3.4483% from yesterday's close, completing a monthly decrease of -23.2737% or -0.18 GBX. Over the past 12 months, FUM stock lost -47.8261%.
FUM is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on LSE (GBX).
Futura Medical plc (FUM) FAQ
What is the stock price today?
The current price is 0.60 GBX.
On which exchange is it traded?
Futura Medical plc is listed on LSE.
What is its stock symbol?
The ticker symbol is FUM.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 142.74M.
Has Futura Medical plc ever had a stock split?
No, there has never been a stock split.
Futura Medical plc Profile
| Biotechnology Industry | Healthcare Sector | Alex Duggan CEO | LSE Exchange | - ISIN |
| GB Country | 14 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Futura Medical plc is a pioneering pharmaceutical company based in Guildford, the United Kingdom, established in 2001. The company is dedicated to developing innovative pharmaceutical and healthcare products with a primary focus on sexual health and pain relief management. Aimed at the consumer healthcare markets, Futura Medical combines scientific rigor with consumer needs to provide solutions that enhance well-being and quality of life.
Products and Services
- MED3000 - A leading product of Futura Medical, MED3000, is a topically applied gel designed for the treatment of erectile dysfunction. This innovative treatment offers a non-invasive method to help improve sexual health and performance.
- TPR100 - This product is a topical pain relief gel formulated with diclofenac, aimed at providing relief from various forms of musculoskeletal pain. TPR100 utilizes advanced technology to ensure effective pain management for users seeking non-oral treatment options.
- CBD100 - A topical cannabidiol formulation developed to harness the therapeutic properties of CBD. CBD100 is designed for users looking for natural pain relief and anti-inflammatory benefits, presenting an alternative approach to pain management.
- TIB200 - Another pain relief solution offered by Futura Medical, TIB200 is a topical gel containing ibuprofen. It aims to provide fast and effective relief from pain and inflammation, suitable for individuals requiring immediate pain management solutions.
Contact Information
Address: Surrey Technology Centre
Phone: 44 14 8368 5670
Website: https://www.futuramedical.com
